• Profile
Close

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: Results from the ADVANCE trial

Diabetologia - Clinical and Experimental Diabetes and Metabolism May 09, 2018

Welsh P, et al. - This trial entailed the quantification of the association of individual circulating amino acids with macrovascular disease, microvascular disease and all-cause mortality in subjects with type 2 diabetes. Phenylalanine, isoleucine, glutamine, leucine, alanine, tyrosine, histidine and valine were measured in stored plasma samples by proton NMR metabolomics. Distinct correlations were brought to light between circulating amino acids and risk of different major complications of diabetes. Findings demonstrated that low tyrosine possibly served as a marker of microvascular risk in individuals with type 2 diabetes independently of fundamental markers of kidney function.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay